Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Kamada Ltd (KMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 231,495
  • Shares Outstanding, K 40,260
  • Annual Sales, $ 102,830 K
  • Annual Income, $ 6,900 K
  • 36-Month Beta 1.20
  • Price/Sales 2.34
  • Price/Cash Flow 23.10
  • Price/Book 2.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.02
  • Number of Estimates 2
  • High Estimate 0.06
  • Low Estimate -0.02
  • Prior Year -0.01
  • Growth Rate Est. (year over year) +300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.74 +0.17%
on 10/18/18
6.45 -10.85%
on 09/25/18
-0.15 (-2.54%)
since 09/18/18
3-Month
4.80 +19.79%
on 08/10/18
6.45 -10.85%
on 09/25/18
+0.20 (+3.60%)
since 07/18/18
52-Week
4.26 +35.14%
on 12/11/17
6.45 -10.85%
on 09/25/18
+0.95 (+19.79%)
since 10/18/17

Most Recent Stories

More News
Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief Executive Officer, will provide a corporate overview at the Cantor Fitzgerald...

KMDA : 5.75 (unch)
Kamada Announces Extension of Collaboration with Massachusetts General Hospital for a Proof-of-Concept Study Evaluating the Potential Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation

Kamada Ltd. (the "Company") (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced the extension of an ongoing investigator initiated, proof-of-concept study evaluating the...

KMDA : 5.75 (unch)
Kamada Provides Updated Full-Year 2018 Revenue Guidance

As result of the recent labor strike part of 2018 shipments are likely to be delayed to early 2019

KMDA : 5.75 (unch)
Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, Board of Directors is proud to announce its addition of Dr Giloz-Ran,...

INTC : 45.00 (+0.07%)
KMDA : 5.75 (unch)
CNBX : 0.6600 (-1.49%)
The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

The Zacks Analyst Blog Highlights: American River, BG Staffing, Evolution Petroleum, Kamada and Farmers & Merchants

AMRB : 15.48 (+4.24%)
EPM : 11.31 (+0.80%)
FMAO : 42.50 (+0.40%)
BGSF : 23.88 (+0.46%)
KMDA : 5.75 (unch)
Dollar Strengthens on Turkey's Trouble: Top 5 Gainers

Lira loses more than 20% over the week as international markets react to the uncertainty over Turkey's capability to repay foreign-currency debts. Dollar hits a one-year high.

AMRB : 15.48 (+4.24%)
EPM : 11.31 (+0.80%)
FMAO : 42.50 (+0.40%)
BGSF : 23.88 (+0.46%)
KMDA : 5.75 (unch)
Kamada (KMDA) Surpasses Q2 Earnings and Revenue Estimates

Kamada (KMDA) delivered earnings and revenue surprises of 55.56% and 14.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 5.75 (unch)
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

-- Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017

KMDA : 5.75 (unch)
Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the quarter and six months ended June 30, 2018, prior to the...

KMDA : 5.75 (unch)
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

Kamada Ltd. (the "Company") (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it has received positive scientific advice from the Committee for Medicinal Products...

KMDA : 5.75 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade KMDA with:

Business Summary

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona,...

See More

Key Turning Points

2nd Resistance Point 5.96
1st Resistance Point 5.85
Last Price 5.75
1st Support Level 5.69
2nd Support Level 5.64

See More

52-Week High 6.45
Last Price 5.75
Fibonacci 61.8% 5.61
Fibonacci 50% 5.35
Fibonacci 38.2% 5.09
52-Week Low 4.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar